IV Bags Market Size Predicted to Advance $3.52 Bn by 2034
The IV bags market is on a steady growth trajectory, driven by an increasing number of hospitalizations, the rising adoption of intravenous therapies, and greater healthcare investments worldwide. Estimated at USD 1.94 billion in 2024, the market is expected to grow to USD 2.06 billion in 2025 and reach USD 3.52 billion by 2034, maintaining a CAGR of 6.14% from 2024 to 2034.
Get All the Details in Our Solution – Download Brochure @ https://www.towardshealthcare.com/download-brochure/5379
The Infusion Economy: Understanding IV Bags
IV bags are essential in medical care, delivering fluids directly into a patient’s bloodstream through a needle or catheter. These bags contain solutions such as normal saline, lactated Ringer’s solution, dextrose, and plasma-lyte, ensuring proper fluid balance in the body. The key components of IV bags include:
Typically, IV bags are made from polyvinyl chloride (PVC), polyethylene, or polypropylene to ensure safe storage and administration of fluids.
We’ve prepared a service to support you. Please feel free to contact us at? [email protected]
Market Trends and Innovations
A significant investment in the IV bags market came in May 2024, when India Life Sciences Fund and Morgan Stanley PE contributed Rs 1,000 crore to Maiva Pharma. This funding will be used to build a new manufacturing facility in Karnataka, India, dedicated to producing sterile dosage forms, including IV bags, pre-filled syringes, and oncology injectables. This move signals a growing demand for advanced, high-quality IV solutions worldwide.
AI’s Transformative Role in IV Bag Management
The integration of Artificial Intelligence (AI) is revolutionizing IV bag usage in healthcare facilities. AI-powered systems can:
Market Drivers, Challenges, and Opportunities
Key Driver: Rising Hospitalizations
The growing number of hospital admissions is a major factor fueling IV bag demand. Conditions such as respiratory disorders, cancer, infections, gastrointestinal diseases, and accidents necessitate IV therapy. According to the World Health Organization (WHO), 421 million patients are hospitalized globally each year, with 5 million adults admitted to ICUs annually. Since up to 80% of hospital patients receive IV fluid therapy, the demand for IV bags continues to rise.
领英推荐
Major Challenge: Supply Chain Disruptions
The increasing demand for IV bags has put pressure on global supply chains. The COVID-19 pandemic, geopolitical issues, and natural disasters have disrupted production and distribution, leading to shortages that affect patient care.
Exciting Opportunity: Sustainable IV Bags
With rising concerns over environmental sustainability, many countries are banning single-use plastics. Traditional IV bags are made from PVC and Di-(2-ethylhexyl)phthalate (DEHP), which pose environmental and health risks. Manufacturers are now shifting towards non-PVC IV bags made from polyolefins like polypropylene and polyethylene. These materials are:
The Future of the IV Bags Market
The IV bags market is evolving with technological advancements, sustainability initiatives, and increasing healthcare demands. AI-driven monitoring, advanced materials, and strategic investments are shaping the future of IV therapy. As hospitals and medical institutions continue to prioritize patient safety and environmental responsibility, the IV bag market is set for substantial growth and innovation in the coming decade.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/iv-bags-market-sizing
Invest in Our Premium Strategic Solution @ https://www.towardshealthcare.com/price/5379
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.dhirubhai.net/company/towards-healthcare